Vimarsana
Biggest News Aggregation in the World

Page 45 - Global Coordinator News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Coordinator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Coordinator Today - Breaking & Trending Today

MaaT Pharma S.A.: MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris - Vimarsana News

MaaT Pharma S.A.: MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris

MaaT Pharma becomes the first company developing microbiome-based drugs to be listed on the regulated market of Euronext Paris Capital increase of €31.5m and which could be increased to €36.2m

Ecoslops Announces A Fund Raising Of Approximately €6m | Hellenic Shipping News Worldwide - Vimarsana News

Ecoslops Announces A Fund Raising Of Approximately €6m | Hellenic Shipping News Worldwide

Ecoslops (Euronext Growth – ALESA – FR0011490648), the cleantech that brings oil into the circular economy, is pleased to announce the launch of two capital increases, with removal of the shareholders’ preferential subscription right and without a priority period, of approximately €6 million (the “Transaction”). Vincent Favier, Chairman and CEO of Ecoslops: “This fund raising ...

Investegate |Synthomer PLC Announcements | Synthomer PLC: PROPOSED PLACING OF NEW ORDINARY SHARES - Vimarsana News

Investegate |Synthomer PLC Announcements | Synthomer PLC: PROPOSED PLACING OF NEW ORDINARY SHARES

Investegate announcements from Synthomer PLC, PROPOSED PLACING OF NEW ORDINARY SHARES

Investegate |Synthomer PLC Announcements | Synthomer PLC: Result of Placing - Vimarsana News

Investegate |Synthomer PLC Announcements | Synthomer PLC: Result of Placing

Investegate announcements from Synthomer PLC, Result of Placing

MaaT Pharma S.A.: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris - Vimarsana News

MaaT Pharma S.A.: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris

Capital increase of 2,333,333 new ordinary shares (corresponding, on an indicative basis, to an amount of approximately €35.0 m1) which may be increased to a maximum of 3,085,831 ordinary new shares